Significance of Clinical-Pathological Correlation in Ponatinib Reactions by Judith Monserrat Corona Herrera, Fanny Carolina López Jiménez, Verónica Monserrat Díaz Sánchez, Betzabé Quiles Martínez, Marcela Saeb Lima, Silvia Méndez Flores

Subjects: “…Ponatinib…”
Get full text

The new HFA/ICOS risk assessment tool to identify patients with chronic myeloid leukaemia at high risk of cardiotoxicity by Daniela Di Lisi, Cristina Madaudo, Giulia Alagna, Marco Santoro, Ludovico Rossetto, Sergio Siragusa, Giuseppina Novo

Subjects: Get full text